Autologous porcine heart cell transplantation improved heart function after a myocardial infarction.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMID 10612762)

Published in J Thorac Cardiovasc Surg on January 01, 2000

Authors

R K Li1, R D Weisel, D A Mickle, Z Q Jia, E J Kim, T Sakai, S Tomita, L Schwartz, M Iwanochko, M Husain, R J Cusimano, R J Burns, T M Yau

Author Affiliations

1: Division of Cardiovascular Surgery, Department of Clinical Biochemistry, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada. RenKe.Li@uhn.on.ca

Articles citing this

Factors released from embryonic stem cells inhibit apoptosis of H9c2 cells. Am J Physiol Heart Circ Physiol (2007) 1.87

Targeted myocardial microinjections of a biocomposite material reduces infarct expansion in pigs. Ann Thorac Surg (2008) 1.82

Factors released from embryonic stem cells inhibit apoptosis in H9c2 cells through PI3K/Akt but not ERK pathway. Am J Physiol Heart Circ Physiol (2008) 1.02

Angiomyogenesis for myocardial repair. Antioxid Redox Signal (2009) 0.93

A porcine model of ischemic heart failure produced by intracoronary injection of ethyl alcohol. Heart Vessels (2010) 0.91

In vivo Differentiation Potential of Mesenchymal Stem Cells: Prenatal and Postnatal Model Systems. Transfus Med Hemother (2008) 0.84

Stem cell death and survival in heart regeneration and repair. Apoptosis (2016) 0.84

Human bone marrow-derived mesenchymal stem cells transplanted into damaged rabbit heart to improve heart function. J Zhejiang Univ Sci B (2005) 0.79

Comparison of two preclinical myocardial infarct models: coronary coil deployment versus surgical ligation. J Transl Med (2014) 0.78

Minimally invasive cell-seeded biomaterial systems for injectable/epicardial implantation in ischemic heart disease. Int J Nanomedicine (2012) 0.77

Genetic modification of xenografts. Curr Top Microbiol Immunol (2003) 0.77

Diabetic heart dysfunction: is cell transplantation a potential therapy? Heart Fail Rev (2003) 0.76

Closed-chest animal model of chronic coronary artery stenosis. Assessment with magnetic resonance imaging. Int J Cardiovasc Imaging (2009) 0.76

Autologous Cell Delivery to the Skin-Implant Interface via the Lumen of Percutaneous Devices in vitro. J Funct Biomater (2010) 0.75

Articles by these authors

Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. N Engl J Med (1999) 5.09

Molecular alteration of the 140-megadalton plasmid associated with loss of virulence and Congo red binding activity in Shigella flexneri. Infect Immun (1986) 4.33

Arabidopsis NPL1: a phototropin homolog controlling the chloroplast high-light avoidance response. Science (2001) 3.93

A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell (1997) 3.65

Physical interaction between a novel domain of the receptor Notch and the transcription factor RBP-J kappa/Su(H). Curr Biol (1995) 3.46

Involvement of RBP-J in biological functions of mouse Notch1 and its derivatives. Development (1997) 3.42

virG, a plasmid-coded virulence gene of Shigella flexneri: identification of the virG protein and determination of the complete coding sequence. J Bacteriol (1989) 3.31

Disruption of the mouse RBP-J kappa gene results in early embryonic death. Development (1995) 3.30

Virulence-associated genetic regions comprising 31 kilobases of the 230-kilobase plasmid in Shigella flexneri 2a. J Bacteriol (1988) 3.24

Autologous transplantation of bone marrow cells improves damaged heart function. Circulation (1999) 3.17

Stress response protein (srp-27) determination in primary human breast carcinomas: clinical, histologic, and prognostic correlations. J Natl Cancer Inst (1991) 3.07

Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg (2002) 2.88

Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst (1992) 2.82

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators. Circulation (1999) 2.79

Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene. Nat Genet (2001) 2.79

Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nat Genet (2001) 2.79

The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev (1998) 2.72

Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless. EMBO J (1994) 2.69

Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice. J Med Chem (1995) 2.62

Some properties of the products of reaction of tadpole collagenase with collagen. Biochemistry (1967) 2.56

The Arabidopsis HKT1 gene homolog mediates inward Na(+) currents in xenopus laevis oocytes and Na(+) uptake in Saccharomyces cerevisiae. Plant Physiol (2000) 2.53

The basic-helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis. Development (1999) 2.46

A case of Trichuris trichiura infection diagnosed by colonoscopy. Am J Gastroenterol (1996) 2.36

A comparative study of fine needle aspiration cytology versus non-aspiration technique in thyroid lesions. Surgeon (2005) 2.35

Maintaining internal representations: the role of the human superior parietal lobe. Nat Neurosci (1998) 2.31

Tolerance to toxic metals by a gene family of phytochelatin synthases from plants and yeast. EMBO J (1999) 2.24

Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites. Biochem Biophys Res Commun (1997) 2.22

DNA sequence and product analysis of the virF locus responsible for congo red binding and cell invasion in Shigella flexneri 2a. Infect Immun (1986) 2.22

Randomized, controlled trial of an interactive videodisc decision aid for patients with ischemic heart disease. J Gen Intern Med (2000) 2.21

Bleeding Dieulafoy's lesions and the choice of endoscopic method: comparing the hemostatic efficacy of mechanical and injection methods. Gastrointest Endosc (2000) 2.16

Efficacy and safety of secondary prophylactic vs. on-demand sucrose-formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13-month crossover study. J Thromb Haemost (2009) 2.16

Angiogenesis by endothelial cell transplantation. J Thorac Cardiovasc Surg (2001) 2.12

Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J Biol Chem (1997) 2.10

Access to medical records for research purposes: varying perceptions across research ethics boards. J Med Ethics (2008) 2.09

Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules. J Exp Med (1999) 2.06

Physiologic observations during partial and total left heart bypass. J Thorac Cardiovasc Surg (1970) 2.05

Molecular cloning of a genetic determinant for Congo red binding ability which is essential for the virulence of Shigella flexneri. Infect Immun (1986) 2.05

Chimeric analysis of fibroblast growth factor receptor-1 (Fgfr1) function: a role for FGFR1 in morphogenetic movement through the primitive streak. Development (1997) 2.01

The phototropin family of photoreceptors. Plant Cell (2001) 2.01

Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen (2008) 2.00

Sexually transmitted papillomaviral infections. I. The anatomic distribution and pathologic grade of neoplastic lesions associated with different viral types. Am J Obstet Gynecol (1987) 1.97

CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Oncogene (1993) 1.95

Lymphohematopoietic cancer in styrene-butadiene polymerization workers. Am J Epidemiol (1992) 1.95

Effect of dexamethasone in combination with caudal analgesia on postoperative pain control in day-case paediatric orchiopexy. Br J Anaesth (2010) 1.93

The "first generation" of endovascular stent-grafts for patients with aneurysms of the descending thoracic aorta. J Thorac Cardiovasc Surg (1998) 1.90

Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells. J Immunol (1998) 1.89

Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J (2000) 1.88

Acute hydrothorax in continuous ambulatory peritoneal dialysis--a collaborative study of 161 centers. Am J Nephrol (1989) 1.88

Prevalence and social correlates of postnatal depression in a low income country. Arch Womens Ment Health (2006) 1.87

Value of Doppler ultrasound parameters of portal vein and hepatic artery in the diagnosis of cirrhosis and portal hypertension. Am J Gastroenterol (1997) 1.85

The transcription factor HNF3beta is required in visceral endoderm for normal primitive streak morphogenesis. Development (1998) 1.85

Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J Biol Chem (1999) 1.83

Deep sternal wound infection: risk factors and outcomes. Ann Thorac Surg (1998) 1.82

To ablate or operate? that is the question! J Am Coll Cardiol (2001) 1.81

The metastasis associated protein S100A4: role in tumour progression and metastasis. Br J Cancer (2005) 1.78

Comparative evaluation of fungal, tubercular, and pyogenic brain abscesses with conventional and diffusion MR imaging and proton MR spectroscopy. AJNR Am J Neuroradiol (2007) 1.78

Repression of shoot growth, a bZIP transcriptional activator, regulates cell elongation by controlling the level of gibberellins. Plant Cell (2000) 1.77

Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation. Proc Natl Acad Sci U S A (1999) 1.76

Mitral valve annuloplasty: the effect of the type on left ventricular function. Ann Thorac Surg (1989) 1.75

Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology (2000) 1.75

Validation of novel imaging methodologies for use as cancer clinical trial end-points. Eur J Cancer (2008) 1.73

Survival and function of bioengineered cardiac grafts. Circulation (1999) 1.72

Transient MR signal changes in patients with generalized tonicoclonic seizure or status epilepticus: periictal diffusion-weighted imaging. AJNR Am J Neuroradiol (2001) 1.72

Overexpression of transforming growth factor-beta1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy. Circulation (1997) 1.69

The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function. Am J Cardiol (2001) 1.68

Portal tumor thrombus due to gastrointestinal cancer. Abdom Imaging (1999) 1.67

Modified application of three-point skull clamp for infants. Neurosurgery (1989) 1.67

Guidelines for reporting morbidity and mortality after cardiac valvular operations. The American Association for Thoracic Surgery, Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Ann Thorac Surg (1996) 1.67

SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease. Exp Neurol (2003) 1.66

Opposite phenotypes of hypomorphic and Y766 phosphorylation site mutations reveal a function for Fgfr1 in anteroposterior patterning of mouse embryos. Genes Dev (1998) 1.65

Functional conservation of mouse Notch receptor family members. FEBS Lett (1996) 1.65

Neuropsychologic impairment after coronary bypass surgery: effect of gaseous microemboli during perfusionist interventions. J Thorac Cardiovasc Surg (2001) 1.64

Salivary prostaglandin concentrations: possible state indicators for major depression. Am J Psychiatry (1989) 1.62

An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer. Br J Cancer (2011) 1.62

Treatment of the modal patient: does one size fit nearly all? J ECT (2001) 1.61

A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group. J Am Soc Nephrol (1999) 1.60

Bicalutamide for advanced prostate cancer: the natural versus treated history of disease. J Clin Oncol (1997) 1.60

Mortality of workers in styrene-butadiene polymer production. J Occup Med (1987) 1.59

An inducible periplasmic blue copper protein from Paracoccus denitrificans. Purification, properties, and physiological role. J Biol Chem (1985) 1.58

A methyl viologen-sensitive mutant of the nematode Caenorhabditis elegans. Mutat Res (1990) 1.58

Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites. Oncogene (2000) 1.58

Prognostic factors in patients with surgically resected stages I and II non-small cell lung cancer. Ann Thorac Surg (2000) 1.58

Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem Pharmacol (1996) 1.58

Plasma thrombospondin levels in patients with colorectal carcinoma. Cancer (1998) 1.57

Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia. Atherosclerosis (1985) 1.55

Hypermethylation in the retinoblastoma gene is associated with unilateral, sporadic retinoblastoma. Cancer Genet Cytogenet (1997) 1.55

ADP-ribosylation of the rhoA gene product by botulinum C3 exoenzyme causes Swiss 3T3 cells to accumulate in the G1 phase of the cell cycle. Oncogene (1993) 1.55